Disclosures for "Brivaracetam Monotherapy Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization Among Patients With Epilepsy: A Cohort Study Using US Claims Data"
-
Dr. Numbere has received personal compensation for serving as an employee of UCB Pharma.
-
Herve Besson has received personal compensation for serving as an employee of UCB.
-
Ms. Kuba has received personal compensation for serving as an employee of UCB.
-
Dr. Bourikas has nothing to disclose.
-
Dr. Pucylowski has received personal compensation for serving as an employee of UCB, Inc.. Dr. Pucylowski has stock in UCB, Inc..
-
Dr. Little has received personal compensation for serving as an employee of UCB.
-
Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has stock in UCB. Dr. Moseley has stock in Neurocrine Biosciences.